Author:
Subasic Christopher N.,Kuilamu Esther,Cowin Gary,Minchin Rodney F.,Kaminskas Lisa M.
Reference47 articles.
1. Pharmacodynamic and pharmacokinetic study of pegylated liposomal doxorubicin combination (CCOP) chemotherapy in patients with peripheral T-cell lymphomas;Fan;Acta Pharmacol. Sin.,2011
2. Pegylated liposomal doxorubicin in the treatment of AIDS-related Kaposi’s sarcoma;Udhrain;Int. J. Nanomedicine,2007
3. Pegylated liposomal doxorubicin for first-line treatment of epithelial ovarian cancer;Lawrie;Cochrane Database Syst. Rev.,2013
4. Factors affecting the pharmacokinetics of pegylated liposomal doxorubicin in patients;La-Beck;Cancer Chemother. Pharmacol.,2012
5. Meta-analysis of inter-patient pharmacokinetic variability of liposomal and non-liposomal anticancer agents;Schell;Nanomedicine,2014
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献